Related Experiment Video
Updated: Aug 10, 2026

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
Published on: October 16, 2015
Stereoselective differences in the binding of N-methylated barbiturates to human serum albumin
1Department of Pharmacology and Toxicology, University of the Saarland, Homburg, Fed. Rep. of Germany.
Abstract:
The binding to human serum albumin (HSA) of a homologous series of N-methylated chiral barbiturates was studied by means of equilibrium dialysis. The length of the aliphatic side chain at C-5 of the barbiturate ring was variable, and the compounds used were: (+)-(S)- and (-)-(R)-5-methyl-(A), -5-ethyl-(B), -5-propyl-(C) and -5-butyl-(D)-1-methyl-5-phenyl-barbiturate. Binding parameters (numbers of binding classes and of binding sites in each class, affinity constant, total binding constant) were obtained from the Scatchard plot of the percent binding values. For both enantiomers of A and D as well as for (-)-(R)-B 2 classes were obtained; (+)-(S)-B and both enantiomers of C had only 1 class. The total binding constant (K) indicated a more than twofold higher binding of (-)-(R)-B (2.64 x 10(3).mol-1) and C (5.75 x 10(3).mol-1) compared with the corresponding (+)-(S)-enantiomer (1.02 and 2.00 x 10(3).mol-1, respectively); in the case of D the (+)-(S)-enantiomer was preferentially bound (K = 10.14 vs. 5.40 x 10(3).mol-1 for the (-)-(R)-enantiomer). The percent binding values of (+)-(S)-A were higher than those of (-)-(R)-A; however, the K-values of the A-enantiomers were almost identical.
More Related Videos
Related Concept Videos
¹H NMR Chemical Shift Equivalence: Enantiotopic and Diastereotopic Protons
In chiral compounds such as 2-butanol, replacing the methylene hydrogens at C3 produces a pair of...
Drug Distribution: Plasma Protein Binding
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

